Evidence map›Paper›PMID 28759018›Full record

ArticleNature chemical biology2017

Toxicity and repair of DNA adducts produced by the natural product yatakemycin.

Elwood A Mullins, Rongxin Shi, Brandt F Eichman

Abstract read
In one paragraph

Article in Nature chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. BorylationOrganic & biomolecular chemistry · 2024
    Article
  8. Review
  9. Review
  10. Bacterial DNA excision repair pathways.Nature reviews. Microbiology · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Target search and recognition mechanisms of glycosylase AlkD revealed by scanning FRET-FCS and Markov state models.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elwood A MullinsDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA.
Rongxin ShiDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA.
Brandt F EichmanDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA.ORCID http://orcid.org/0000-0002-0965-2297
Vanderbilt University · US

Funding

TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007028 · NIEHS · VANDERBILT UNIVERSITY · PI F PETER Guengerich, Fiona Edith Harrison · 1985 to 2026
$15.7M
Mechanisms of selective excision and oxidative repair of alkylated DNAR01ES019625 · NIEHS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI CAMPS, MANEL · 2011 to 2015
$1.7M
NIEHS NIH HHS R01 ES019625NIEHS NIH HHS T32 ES007028
6 · The paper itself

Abstract

Yatakemycin (YTM) is an extraordinarily toxic DNA alkylating agent with potent antimicrobial and antitumor properties and is the most recent addition to the CC-1065 and duocarmycin family of natural products. Though bulky DNA lesions the size of those produced by YTM are normally removed from the genome by the nucleotide-excision repair (NER) pathway, YTM adducts are also a substrate for the bacterial DNA glycosylases AlkD and YtkR2, unexpectedly implicating base-excision repair (BER) in their elimination. The reason for the extreme toxicity of these lesions and the molecular basis for the way they are eliminated by BER have been unclear. Here, we describe the structural and biochemical properties of YTM adducts that are responsible for their toxicity, and define the mechanism by which they are excised by AlkD. These findings delineate an alternative strategy for repair of bulky DNA damage and establish the cellular utility of this pathway relative to that of NER.

Indexed as

Biological ProductsDNA AdductsDNA DamageDNA RepairDrug Resistance, BacterialDuocarmycinsIndolesMolecular StructurePyrrolesBiological ProductsDNA AdductsDuocarmycinsIndolesPyrrolesyatakemycin

Identifiers

PMID28759018
PMCPMC5657529
OpenAlexW2739173570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.